Cargando...
Past, Current, and Future of Immunotherapies for Prostate Cancer
Prostate cancer (PCa) is the most common cancer in men, and the second leading cause of cancer related death in men in Western countries. The standard therapy for metastatic PCa is androgen suppression therapy (AST). Men undergoing AST eventually develop metastatic castration-resistant prostate canc...
Gardado en:
| Publicado en: | Front Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6749031/ https://ncbi.nlm.nih.gov/pubmed/31572678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00884 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|